Patients experience slurred speech (dysarthria) and difficulty swallowing (dysphagia) early in the disease progression. Bulbar-onset ALS usually exhibits a rapid evolution and poor prognosis (~26 ...

The ultimate goal for much ALS research is to find therapeutic interventions that can slow or reverse disease progression. In order to evaluate such interventions, disease progression biomarkers ...